“…(However, see Lesca et al (2013) for evidence that casts doubt on the role of uPAR/ SRPX2 in this disorder, instead implicating a different gene, GRIN2A). Intriguingly, SRPX2 regulation by FOXP2 is thought to be an important mediator of synaptogenesis (Sia, Clem, & Huganir, 2013). Other FOXP2 targets of particular clinical relevance include the receptor tyrosine kinase MET, proposed as a candidate for autism (Mukamel et al, 2011), and DISC1, a gene that was originally implicated in schizophrenia (Walker et al, 2012).…”